Found 12 hits for monomerid = 50458012 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Proteasome subunit beta type-1/beta type-5
(Homo sapiens (Human)) | BDBM50458012
(CHEMBL4212401)Show SMILES [#6]-[#6]\[#6](=[#6](\c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1cccc(c1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](-[#7])=O |r| Show InChI InChI=1S/C89H150N36O12/c1-2-62(72(56-30-34-60(35-31-56)136-52-50-124-46-7-3-4-8-47-124)57-32-36-61(37-33-57)137-53-51-125-48-9-5-6-10-49-125)58-20-11-21-59(54-58)74(128)115-55-71(126)116-64(23-13-39-108-83(93)94)75(129)118-66(25-15-41-110-85(97)98)77(131)120-68(27-17-43-112-87(101)102)79(133)122-70(29-19-45-114-89(105)106)81(135)123-69(28-18-44-113-88(103)104)80(134)121-67(26-16-42-111-86(99)100)78(132)119-65(24-14-40-109-84(95)96)76(130)117-63(73(90)127)22-12-38-107-82(91)92/h11,20-21,30-37,54,63-70H,2-10,12-19,22-29,38-53,55H2,1H3,(H2,90,127)(H,115,128)(H,116,126)(H,117,130)(H,118,129)(H,119,132)(H,120,131)(H,121,134)(H,122,133)(H,123,135)(H4,91,92,107)(H4,93,94,108)(H4,95,96,109)(H4,97,98,110)(H4,99,100,111)(H4,101,102,112)(H4,103,104,113)(H4,105,106,114)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 6.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Nagahama Institute of Bio-Science and Technology
Curated by ChEMBL
| Assay Description Inhibition of chymotrypsin-like activity of 26S proteasome in human KMS11 cells using Suc-LLVY-MCA as substrate after 24 to 48 hrs by luminescence-ba... |
Eur J Med Chem 146: 636-650 (2018)
Article DOI: 10.1016/j.ejmech.2018.01.045 BindingDB Entry DOI: 10.7270/Q2DF6TV7 |
More data for this Ligand-Target Pair | |
Proteasome Macropain subunit
(Homo sapiens (Human)) | BDBM50458012
(CHEMBL4212401)Show SMILES [#6]-[#6]\[#6](=[#6](\c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1cccc(c1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](-[#7])=O |r| Show InChI InChI=1S/C89H150N36O12/c1-2-62(72(56-30-34-60(35-31-56)136-52-50-124-46-7-3-4-8-47-124)57-32-36-61(37-33-57)137-53-51-125-48-9-5-6-10-49-125)58-20-11-21-59(54-58)74(128)115-55-71(126)116-64(23-13-39-108-83(93)94)75(129)118-66(25-15-41-110-85(97)98)77(131)120-68(27-17-43-112-87(101)102)79(133)122-70(29-19-45-114-89(105)106)81(135)123-69(28-18-44-113-88(103)104)80(134)121-67(26-16-42-111-86(99)100)78(132)119-65(24-14-40-109-84(95)96)76(130)117-63(73(90)127)22-12-38-107-82(91)92/h11,20-21,30-37,54,63-70H,2-10,12-19,22-29,38-53,55H2,1H3,(H2,90,127)(H,115,128)(H,116,126)(H,117,130)(H,118,129)(H,119,132)(H,120,131)(H,121,134)(H,122,133)(H,123,135)(H4,91,92,107)(H4,93,94,108)(H4,95,96,109)(H4,97,98,110)(H4,99,100,111)(H4,101,102,112)(H4,103,104,113)(H4,105,106,114)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 8.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Nagahama Institute of Bio-Science and Technology
Curated by ChEMBL
| Assay Description Inhibition of trypsin-like activity of 26S proteasome in human KMS11 cells using Boc-LRR-MCA as substrate after 24 to 48 hrs by luminescence-based as... |
Eur J Med Chem 146: 636-650 (2018)
Article DOI: 10.1016/j.ejmech.2018.01.045 BindingDB Entry DOI: 10.7270/Q2DF6TV7 |
More data for this Ligand-Target Pair | |
Proteasome Macropain subunit
(Homo sapiens (Human)) | BDBM50458012
(CHEMBL4212401)Show SMILES [#6]-[#6]\[#6](=[#6](\c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1cccc(c1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](-[#7])=O |r| Show InChI InChI=1S/C89H150N36O12/c1-2-62(72(56-30-34-60(35-31-56)136-52-50-124-46-7-3-4-8-47-124)57-32-36-61(37-33-57)137-53-51-125-48-9-5-6-10-49-125)58-20-11-21-59(54-58)74(128)115-55-71(126)116-64(23-13-39-108-83(93)94)75(129)118-66(25-15-41-110-85(97)98)77(131)120-68(27-17-43-112-87(101)102)79(133)122-70(29-19-45-114-89(105)106)81(135)123-69(28-18-44-113-88(103)104)80(134)121-67(26-16-42-111-86(99)100)78(132)119-65(24-14-40-109-84(95)96)76(130)117-63(73(90)127)22-12-38-107-82(91)92/h11,20-21,30-37,54,63-70H,2-10,12-19,22-29,38-53,55H2,1H3,(H2,90,127)(H,115,128)(H,116,126)(H,117,130)(H,118,129)(H,119,132)(H,120,131)(H,121,134)(H,122,133)(H,123,135)(H4,91,92,107)(H4,93,94,108)(H4,95,96,109)(H4,97,98,110)(H4,99,100,111)(H4,101,102,112)(H4,103,104,113)(H4,105,106,114)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Nagahama Institute of Bio-Science and Technology
Curated by ChEMBL
| Assay Description Inhibition of trypsin-like activity of human 20S proteasome using Boc-LRR-MCA as substrate measured for 1 hr by fluorescence assay |
Eur J Med Chem 146: 636-650 (2018)
Article DOI: 10.1016/j.ejmech.2018.01.045 BindingDB Entry DOI: 10.7270/Q2DF6TV7 |
More data for this Ligand-Target Pair | |
Proteasome component C5
(Homo sapiens (Human)) | BDBM50458012
(CHEMBL4212401)Show SMILES [#6]-[#6]\[#6](=[#6](\c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1cccc(c1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](-[#7])=O |r| Show InChI InChI=1S/C89H150N36O12/c1-2-62(72(56-30-34-60(35-31-56)136-52-50-124-46-7-3-4-8-47-124)57-32-36-61(37-33-57)137-53-51-125-48-9-5-6-10-49-125)58-20-11-21-59(54-58)74(128)115-55-71(126)116-64(23-13-39-108-83(93)94)75(129)118-66(25-15-41-110-85(97)98)77(131)120-68(27-17-43-112-87(101)102)79(133)122-70(29-19-45-114-89(105)106)81(135)123-69(28-18-44-113-88(103)104)80(134)121-67(26-16-42-111-86(99)100)78(132)119-65(24-14-40-109-84(95)96)76(130)117-63(73(90)127)22-12-38-107-82(91)92/h11,20-21,30-37,54,63-70H,2-10,12-19,22-29,38-53,55H2,1H3,(H2,90,127)(H,115,128)(H,116,126)(H,117,130)(H,118,129)(H,119,132)(H,120,131)(H,121,134)(H,122,133)(H,123,135)(H4,91,92,107)(H4,93,94,108)(H4,95,96,109)(H4,97,98,110)(H4,99,100,111)(H4,101,102,112)(H4,103,104,113)(H4,105,106,114)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Nagahama Institute of Bio-Science and Technology
Curated by ChEMBL
| Assay Description Inhibition of PGPH activity of human 20S proteasome using Z-LLE-MCA as substrate measured for 1 hr by fluorescence assay |
Eur J Med Chem 146: 636-650 (2018)
Article DOI: 10.1016/j.ejmech.2018.01.045 BindingDB Entry DOI: 10.7270/Q2DF6TV7 |
More data for this Ligand-Target Pair | |
Proteasome subunit beta type-1/beta type-5
(Homo sapiens (Human)) | BDBM50458012
(CHEMBL4212401)Show SMILES [#6]-[#6]\[#6](=[#6](\c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1cccc(c1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](-[#7])=O |r| Show InChI InChI=1S/C89H150N36O12/c1-2-62(72(56-30-34-60(35-31-56)136-52-50-124-46-7-3-4-8-47-124)57-32-36-61(37-33-57)137-53-51-125-48-9-5-6-10-49-125)58-20-11-21-59(54-58)74(128)115-55-71(126)116-64(23-13-39-108-83(93)94)75(129)118-66(25-15-41-110-85(97)98)77(131)120-68(27-17-43-112-87(101)102)79(133)122-70(29-19-45-114-89(105)106)81(135)123-69(28-18-44-113-88(103)104)80(134)121-67(26-16-42-111-86(99)100)78(132)119-65(24-14-40-109-84(95)96)76(130)117-63(73(90)127)22-12-38-107-82(91)92/h11,20-21,30-37,54,63-70H,2-10,12-19,22-29,38-53,55H2,1H3,(H2,90,127)(H,115,128)(H,116,126)(H,117,130)(H,118,129)(H,119,132)(H,120,131)(H,121,134)(H,122,133)(H,123,135)(H4,91,92,107)(H4,93,94,108)(H4,95,96,109)(H4,97,98,110)(H4,99,100,111)(H4,101,102,112)(H4,103,104,113)(H4,105,106,114)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Nagahama Institute of Bio-Science and Technology
Curated by ChEMBL
| Assay Description Inhibition of chymotrypsin-like activity of human 20S proteasome using Suc-LLVY-MCA as substrate measured for 1 hr by fluorescence assay |
Eur J Med Chem 146: 636-650 (2018)
Article DOI: 10.1016/j.ejmech.2018.01.045 BindingDB Entry DOI: 10.7270/Q2DF6TV7 |
More data for this Ligand-Target Pair | |
Proteasome subunit beta type-1/beta type-5
(Homo sapiens (Human)) | BDBM50458012
(CHEMBL4212401)Show SMILES [#6]-[#6]\[#6](=[#6](\c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1cccc(c1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](-[#7])=O |r| Show InChI InChI=1S/C89H150N36O12/c1-2-62(72(56-30-34-60(35-31-56)136-52-50-124-46-7-3-4-8-47-124)57-32-36-61(37-33-57)137-53-51-125-48-9-5-6-10-49-125)58-20-11-21-59(54-58)74(128)115-55-71(126)116-64(23-13-39-108-83(93)94)75(129)118-66(25-15-41-110-85(97)98)77(131)120-68(27-17-43-112-87(101)102)79(133)122-70(29-19-45-114-89(105)106)81(135)123-69(28-18-44-113-88(103)104)80(134)121-67(26-16-42-111-86(99)100)78(132)119-65(24-14-40-109-84(95)96)76(130)117-63(73(90)127)22-12-38-107-82(91)92/h11,20-21,30-37,54,63-70H,2-10,12-19,22-29,38-53,55H2,1H3,(H2,90,127)(H,115,128)(H,116,126)(H,117,130)(H,118,129)(H,119,132)(H,120,131)(H,121,134)(H,122,133)(H,123,135)(H4,91,92,107)(H4,93,94,108)(H4,95,96,109)(H4,97,98,110)(H4,99,100,111)(H4,101,102,112)(H4,103,104,113)(H4,105,106,114)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Nagahama Institute of Bio-Science and Technology
Curated by ChEMBL
| Assay Description Inhibition of chymotrypsin-like activity of human 26S proteasome using Suc-LLVY-MCA as substrate measured for 1 hr by fluorescence assay |
Eur J Med Chem 146: 636-650 (2018)
Article DOI: 10.1016/j.ejmech.2018.01.045 BindingDB Entry DOI: 10.7270/Q2DF6TV7 |
More data for this Ligand-Target Pair | |
Proteasome Macropain subunit
(Homo sapiens (Human)) | BDBM50458012
(CHEMBL4212401)Show SMILES [#6]-[#6]\[#6](=[#6](\c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1cccc(c1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](-[#7])=O |r| Show InChI InChI=1S/C89H150N36O12/c1-2-62(72(56-30-34-60(35-31-56)136-52-50-124-46-7-3-4-8-47-124)57-32-36-61(37-33-57)137-53-51-125-48-9-5-6-10-49-125)58-20-11-21-59(54-58)74(128)115-55-71(126)116-64(23-13-39-108-83(93)94)75(129)118-66(25-15-41-110-85(97)98)77(131)120-68(27-17-43-112-87(101)102)79(133)122-70(29-19-45-114-89(105)106)81(135)123-69(28-18-44-113-88(103)104)80(134)121-67(26-16-42-111-86(99)100)78(132)119-65(24-14-40-109-84(95)96)76(130)117-63(73(90)127)22-12-38-107-82(91)92/h11,20-21,30-37,54,63-70H,2-10,12-19,22-29,38-53,55H2,1H3,(H2,90,127)(H,115,128)(H,116,126)(H,117,130)(H,118,129)(H,119,132)(H,120,131)(H,121,134)(H,122,133)(H,123,135)(H4,91,92,107)(H4,93,94,108)(H4,95,96,109)(H4,97,98,110)(H4,99,100,111)(H4,101,102,112)(H4,103,104,113)(H4,105,106,114)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 4.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Nagahama Institute of Bio-Science and Technology
Curated by ChEMBL
| Assay Description Inhibition of trypsin-like activity of human 26S proteasome using Boc-LRR-MCA as substrate measured for 1 hr by fluorescence assay |
Eur J Med Chem 146: 636-650 (2018)
Article DOI: 10.1016/j.ejmech.2018.01.045 BindingDB Entry DOI: 10.7270/Q2DF6TV7 |
More data for this Ligand-Target Pair | |
Proteasome subunit beta type-1/beta type-5
(Homo sapiens (Human)) | BDBM50458012
(CHEMBL4212401)Show SMILES [#6]-[#6]\[#6](=[#6](\c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1cccc(c1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](-[#7])=O |r| Show InChI InChI=1S/C89H150N36O12/c1-2-62(72(56-30-34-60(35-31-56)136-52-50-124-46-7-3-4-8-47-124)57-32-36-61(37-33-57)137-53-51-125-48-9-5-6-10-49-125)58-20-11-21-59(54-58)74(128)115-55-71(126)116-64(23-13-39-108-83(93)94)75(129)118-66(25-15-41-110-85(97)98)77(131)120-68(27-17-43-112-87(101)102)79(133)122-70(29-19-45-114-89(105)106)81(135)123-69(28-18-44-113-88(103)104)80(134)121-67(26-16-42-111-86(99)100)78(132)119-65(24-14-40-109-84(95)96)76(130)117-63(73(90)127)22-12-38-107-82(91)92/h11,20-21,30-37,54,63-70H,2-10,12-19,22-29,38-53,55H2,1H3,(H2,90,127)(H,115,128)(H,116,126)(H,117,130)(H,118,129)(H,119,132)(H,120,131)(H,121,134)(H,122,133)(H,123,135)(H4,91,92,107)(H4,93,94,108)(H4,95,96,109)(H4,97,98,110)(H4,99,100,111)(H4,101,102,112)(H4,103,104,113)(H4,105,106,114)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 2.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Nagahama Institute of Bio-Science and Technology
Curated by ChEMBL
| Assay Description Inhibition of chymotrypsin-like activity of human 26S proteasome using Z-LLE-MCA as substrate measured for 1 hr in presence of ATPgammaS by fluoresce... |
Eur J Med Chem 146: 636-650 (2018)
Article DOI: 10.1016/j.ejmech.2018.01.045 BindingDB Entry DOI: 10.7270/Q2DF6TV7 |
More data for this Ligand-Target Pair | |
Proteasome component C5
(Homo sapiens (Human)) | BDBM50458012
(CHEMBL4212401)Show SMILES [#6]-[#6]\[#6](=[#6](\c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1cccc(c1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](-[#7])=O |r| Show InChI InChI=1S/C89H150N36O12/c1-2-62(72(56-30-34-60(35-31-56)136-52-50-124-46-7-3-4-8-47-124)57-32-36-61(37-33-57)137-53-51-125-48-9-5-6-10-49-125)58-20-11-21-59(54-58)74(128)115-55-71(126)116-64(23-13-39-108-83(93)94)75(129)118-66(25-15-41-110-85(97)98)77(131)120-68(27-17-43-112-87(101)102)79(133)122-70(29-19-45-114-89(105)106)81(135)123-69(28-18-44-113-88(103)104)80(134)121-67(26-16-42-111-86(99)100)78(132)119-65(24-14-40-109-84(95)96)76(130)117-63(73(90)127)22-12-38-107-82(91)92/h11,20-21,30-37,54,63-70H,2-10,12-19,22-29,38-53,55H2,1H3,(H2,90,127)(H,115,128)(H,116,126)(H,117,130)(H,118,129)(H,119,132)(H,120,131)(H,121,134)(H,122,133)(H,123,135)(H4,91,92,107)(H4,93,94,108)(H4,95,96,109)(H4,97,98,110)(H4,99,100,111)(H4,101,102,112)(H4,103,104,113)(H4,105,106,114)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 4.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Nagahama Institute of Bio-Science and Technology
Curated by ChEMBL
| Assay Description Inhibition of PGPH-like activity of 26S proteasome in human KMS11 cells using Z-LLE-MCA as substrate after 24 to 48 hrs by luminescence-based assay |
Eur J Med Chem 146: 636-650 (2018)
Article DOI: 10.1016/j.ejmech.2018.01.045 BindingDB Entry DOI: 10.7270/Q2DF6TV7 |
More data for this Ligand-Target Pair | |
Proteasome subunit beta type-1/beta type-5
(Homo sapiens (Human)) | BDBM50458012
(CHEMBL4212401)Show SMILES [#6]-[#6]\[#6](=[#6](\c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1cccc(c1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](-[#7])=O |r| Show InChI InChI=1S/C89H150N36O12/c1-2-62(72(56-30-34-60(35-31-56)136-52-50-124-46-7-3-4-8-47-124)57-32-36-61(37-33-57)137-53-51-125-48-9-5-6-10-49-125)58-20-11-21-59(54-58)74(128)115-55-71(126)116-64(23-13-39-108-83(93)94)75(129)118-66(25-15-41-110-85(97)98)77(131)120-68(27-17-43-112-87(101)102)79(133)122-70(29-19-45-114-89(105)106)81(135)123-69(28-18-44-113-88(103)104)80(134)121-67(26-16-42-111-86(99)100)78(132)119-65(24-14-40-109-84(95)96)76(130)117-63(73(90)127)22-12-38-107-82(91)92/h11,20-21,30-37,54,63-70H,2-10,12-19,22-29,38-53,55H2,1H3,(H2,90,127)(H,115,128)(H,116,126)(H,117,130)(H,118,129)(H,119,132)(H,120,131)(H,121,134)(H,122,133)(H,123,135)(H4,91,92,107)(H4,93,94,108)(H4,95,96,109)(H4,97,98,110)(H4,99,100,111)(H4,101,102,112)(H4,103,104,113)(H4,105,106,114)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 5.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Nagahama Institute of Bio-Science and Technology
Curated by ChEMBL
| Assay Description Inhibition of chymotrypsin-like activity of 26S proteasome in human RPMI8226 cells using Suc-LLVY-MCA as substrate after 24 to 48 hrs by luminescence... |
Eur J Med Chem 146: 636-650 (2018)
Article DOI: 10.1016/j.ejmech.2018.01.045 BindingDB Entry DOI: 10.7270/Q2DF6TV7 |
More data for this Ligand-Target Pair | |
Proteasome component C5
(Homo sapiens (Human)) | BDBM50458012
(CHEMBL4212401)Show SMILES [#6]-[#6]\[#6](=[#6](\c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1cccc(c1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](-[#7])=O |r| Show InChI InChI=1S/C89H150N36O12/c1-2-62(72(56-30-34-60(35-31-56)136-52-50-124-46-7-3-4-8-47-124)57-32-36-61(37-33-57)137-53-51-125-48-9-5-6-10-49-125)58-20-11-21-59(54-58)74(128)115-55-71(126)116-64(23-13-39-108-83(93)94)75(129)118-66(25-15-41-110-85(97)98)77(131)120-68(27-17-43-112-87(101)102)79(133)122-70(29-19-45-114-89(105)106)81(135)123-69(28-18-44-113-88(103)104)80(134)121-67(26-16-42-111-86(99)100)78(132)119-65(24-14-40-109-84(95)96)76(130)117-63(73(90)127)22-12-38-107-82(91)92/h11,20-21,30-37,54,63-70H,2-10,12-19,22-29,38-53,55H2,1H3,(H2,90,127)(H,115,128)(H,116,126)(H,117,130)(H,118,129)(H,119,132)(H,120,131)(H,121,134)(H,122,133)(H,123,135)(H4,91,92,107)(H4,93,94,108)(H4,95,96,109)(H4,97,98,110)(H4,99,100,111)(H4,101,102,112)(H4,103,104,113)(H4,105,106,114)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | 6.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Nagahama Institute of Bio-Science and Technology
Curated by ChEMBL
| Assay Description Inhibition of PGPH-like activity of 26S proteasome in human RPMI8226 cells using Z-LLE-MCA as substrate after 24 to 48 hrs by luminescence-based assa... |
Eur J Med Chem 146: 636-650 (2018)
Article DOI: 10.1016/j.ejmech.2018.01.045 BindingDB Entry DOI: 10.7270/Q2DF6TV7 |
More data for this Ligand-Target Pair | |
Proteasome component C5
(Homo sapiens (Human)) | BDBM50458012
(CHEMBL4212401)Show SMILES [#6]-[#6]\[#6](=[#6](\c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1ccc(-[#8]-[#6]-[#6]-[#7]-2-[#6]-[#6]-[#6]-[#6]-[#6]-[#6]-2)cc1)-c1cccc(c1)-[#6](=O)-[#7]-[#6]-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](=O)-[#7]-[#6@@H](-[#6]-[#6]-[#6]-[#7]-[#6](-[#7])=[#7])-[#6](-[#7])=O |r| Show InChI InChI=1S/C89H150N36O12/c1-2-62(72(56-30-34-60(35-31-56)136-52-50-124-46-7-3-4-8-47-124)57-32-36-61(37-33-57)137-53-51-125-48-9-5-6-10-49-125)58-20-11-21-59(54-58)74(128)115-55-71(126)116-64(23-13-39-108-83(93)94)75(129)118-66(25-15-41-110-85(97)98)77(131)120-68(27-17-43-112-87(101)102)79(133)122-70(29-19-45-114-89(105)106)81(135)123-69(28-18-44-113-88(103)104)80(134)121-67(26-16-42-111-86(99)100)78(132)119-65(24-14-40-109-84(95)96)76(130)117-63(73(90)127)22-12-38-107-82(91)92/h11,20-21,30-37,54,63-70H,2-10,12-19,22-29,38-53,55H2,1H3,(H2,90,127)(H,115,128)(H,116,126)(H,117,130)(H,118,129)(H,119,132)(H,120,131)(H,121,134)(H,122,133)(H,123,135)(H4,91,92,107)(H4,93,94,108)(H4,95,96,109)(H4,97,98,110)(H4,99,100,111)(H4,101,102,112)(H4,103,104,113)(H4,105,106,114)/t63-,64-,65-,66-,67-,68-,69-,70-/m0/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| Article PubMed
| n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Nagahama Institute of Bio-Science and Technology
Curated by ChEMBL
| Assay Description Inhibition of PGPH activity of human 26S proteasome using Z-LLE-MCA as substrate measured for 1 hr by fluorescence assay |
Eur J Med Chem 146: 636-650 (2018)
Article DOI: 10.1016/j.ejmech.2018.01.045 BindingDB Entry DOI: 10.7270/Q2DF6TV7 |
More data for this Ligand-Target Pair | |